Comparison of Prox1 expressing and Prox1 knockout intestinal tumors and the effect of A2V+CD40
收藏NIAID Data Ecosystem2026-04-25 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP176286
下载链接
链接失效反馈官方服务：
资源简介：
Control or A2V+CD40 treated Prox1-proficient (AP) and Prox1-deficient (APP) tumors Overall design: Tumors induced in Apcflox/flox;Tp53flox/flox;villin-CreERT2 (AP) or Apcflox/flox;Tp53flox/flox;Prox1flox/flox;villin-CreERT2 (APP) mice for two weeks. Mice were randomized and treated with PBS, control IgG, or A2V+CD40 for two weeks.
创建时间：
2020-05-08
